Pfizer delays Exubera launch
Pfizer said it would delay the launch of its inhaled insulin Exubera until early September, weeks later than its previously ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.